本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Teladoc Health Inc.

6.16
+0.07001.15%
盤後6.15-0.0100-0.16%19:55 EDT
成交量:256.62萬
成交額:1,575.33萬
市值:11.19億
市盈率:-6.21
高:6.20
開:6.09
低:6.04
收:6.09
52周最高:9.89
52周最低:4.40
股本:1.82億
流通股本:1.81億
量比:0.82
換手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):-0.9925
每股收益(LYR):-1.1400
淨資產收益率:-12.99%
總資產收益率:-3.22%
市淨率:0.85
市盈率(LYR):-5.40

資料載入中...

2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/21

重要事件披露

Form 8-K - Current report
2026/04/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/31

重要事件披露

Form 8-K - Current report
2026/03/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/19

重要事件披露

Form 8-K - Current report